메뉴 건너뛰기




Volumn 410, Issue 1, 2000, Pages 53-59

Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine

Author keywords

5 HT1B 1D receptor agonist; Almotriptan; Cardiovascular safety; Migraine

Indexed keywords

ALMOTRIPTAN; SUMATRIPTAN;

EID: 0034694789     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00878-5     Document Type: Article
Times cited : (17)

References (24)
  • 1
    • 0001127258 scopus 로고
    • An analysis of the time-relations of electrocardiogram
    • (1920) Heart , vol.7 , pp. 353-370
    • Bazett, H.C.1
  • 22
    • 0015980457 scopus 로고
    • Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine-studies in an experimental model for migraine
    • (1974) Headache , vol.13 , pp. 44-54
    • Saxena, P.R.1    Vlaam-Schluter, G.M.2
  • 24
    • 0000894788 scopus 로고    scopus 로고
    • Sumatriptan in clinical practice. A 2-year review of its effects and limitations
    • Olesen, J. and Tfelt-Hansen, P. (Eds.), Headache Treatments. Trial Methodology and New Drugs. Lippincott-Raven, Philadelphia-New York
    • (1997) , pp. 181-188
    • Visser, W.H.1    Ferrari, M.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.